Titan Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8883143096
Pharmaceuticals
Sales 2022 | 557K 44.35M | Sales 2023 | 184K 14.65M | Capitalization | 6.21M 495M |
---|---|---|---|---|---|
Net income 2022 | -10M -796M | Net income 2023 | -5M -398M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M 219M | Net cash position 2023 | 6.2M 493M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 14/08/22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 11/10/23 |
Brynner Chiam
BRD | Director/Board Member | - | 11/10/23 |
1st Jan change | Capi. | |
---|---|---|
+26.15% | 661B | |
+26.74% | 566B | |
-6.67% | 352B | |
+19.24% | 332B | |
+3.32% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.29% | 145B |